TC
SRNE

Talkot Capital’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Talkot Capital’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-145,500
Closed -$1.68M – 27
2015
Q1 		$1.68M Sell
145,500
-239,057
-62% -$2.77M 1.15% 15
2014
Q4 		$3.87M Sell
384,557
-419,494
-52% -$2.13M 2.92% 9
2014
Q3 		$3.63M Buy
804,051
+108,242
+16% +$581K 2.55% 10
2014
Q2 		$4.7M Buy
+695,809
New +$5.25M 3.19% 10

Other funds holding SRNE

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Talkot Capital's SRNE Position: Q2 2015 in Review

Talkot Capital sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2015, closing a stake of 145,500 shares — an estimated $1.68M sold.

Talkot Capital first reported a position in SRNE in Q2 2014 and held it in 4 quarters. The position peaked at $4.7M in Q2 2014. 75 funds tracked by Wall St. Rank hold SRNE as of Q2 2015.

  • Talkot Capital reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2015 after selling out during the quarter.
  • Talkot Capital sold 145,500 Sorrento Therapeutics, Inc. shares in Q2 2015, an estimated $1.68M.
  • Talkot Capital first reported a position in Sorrento Therapeutics, Inc. in Q2 2014 and held it in 4 quarters.
  • Talkot Capital's Sorrento Therapeutics, Inc. position peaked at $4.7M in Q2 2014.
  • 75 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2015.

Based on Talkot Capital's 13F filing for Q2 2015, filed 13 Aug 2015.